MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy

Hamed Mirzaei, Fatemeh Momeni, Leila Saadatpour, Amirhossein Sahebkar, Mohammad Goodarzi, Aria Masoudifar, Shirin Kouhpayeh, Hossein Salehi, Hamid Reza Mirzaei, Mahmoud Reza Jaafari

Research output: Contribution to journalReview article

64 Citations (Scopus)

Abstract

Stroke is a life-threatening disease that accounts for a considerable burden of mortality in both developing and developed world. Identification of specific biomarkers for stroke and its outcomes can greatly contribute to improved care of patients. MicroRNAs (miRNAs) are known as novel biomarkers that could be used as diagnostic, prognostic, and therapeutic biomarkers. Various studies have shown that miRNAs have key roles in the pathogenesis of stroke, and its complications and outcomes. In addition, there is evidence showing that mesenchaymal stromal cell-derived exosomes containing miRNAs can be used for monitoring and treatment of various diseases such as stroke. Here, we summarized various aspects of miRNA applications in different stages of stroke.

Original languageEnglish (US)
Pages (from-to)856-865
Number of pages10
JournalJournal of Cellular Physiology
Volume233
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

MicroRNAs
Biomarkers
Stroke
Exosomes
Therapeutics
Stromal Cells
Patient Care
Monitoring
Mortality

Keywords

  • biomarker
  • exosome
  • meseanchaymal stromal cell
  • microRNA
  • stroke

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Mirzaei, H., Momeni, F., Saadatpour, L., Sahebkar, A., Goodarzi, M., Masoudifar, A., ... Jaafari, M. R. (2018). MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy. Journal of Cellular Physiology, 233(2), 856-865. https://doi.org/10.1002/jcp.25787

MicroRNA : Relevance to stroke diagnosis, prognosis, and therapy. / Mirzaei, Hamed; Momeni, Fatemeh; Saadatpour, Leila; Sahebkar, Amirhossein; Goodarzi, Mohammad; Masoudifar, Aria; Kouhpayeh, Shirin; Salehi, Hossein; Mirzaei, Hamid Reza; Jaafari, Mahmoud Reza.

In: Journal of Cellular Physiology, Vol. 233, No. 2, 01.02.2018, p. 856-865.

Research output: Contribution to journalReview article

Mirzaei, H, Momeni, F, Saadatpour, L, Sahebkar, A, Goodarzi, M, Masoudifar, A, Kouhpayeh, S, Salehi, H, Mirzaei, HR & Jaafari, MR 2018, 'MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy', Journal of Cellular Physiology, vol. 233, no. 2, pp. 856-865. https://doi.org/10.1002/jcp.25787
Mirzaei H, Momeni F, Saadatpour L, Sahebkar A, Goodarzi M, Masoudifar A et al. MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy. Journal of Cellular Physiology. 2018 Feb 1;233(2):856-865. https://doi.org/10.1002/jcp.25787
Mirzaei, Hamed ; Momeni, Fatemeh ; Saadatpour, Leila ; Sahebkar, Amirhossein ; Goodarzi, Mohammad ; Masoudifar, Aria ; Kouhpayeh, Shirin ; Salehi, Hossein ; Mirzaei, Hamid Reza ; Jaafari, Mahmoud Reza. / MicroRNA : Relevance to stroke diagnosis, prognosis, and therapy. In: Journal of Cellular Physiology. 2018 ; Vol. 233, No. 2. pp. 856-865.
@article{3505de7dd72842a48e447daf26d5dadb,
title = "MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy",
abstract = "Stroke is a life-threatening disease that accounts for a considerable burden of mortality in both developing and developed world. Identification of specific biomarkers for stroke and its outcomes can greatly contribute to improved care of patients. MicroRNAs (miRNAs) are known as novel biomarkers that could be used as diagnostic, prognostic, and therapeutic biomarkers. Various studies have shown that miRNAs have key roles in the pathogenesis of stroke, and its complications and outcomes. In addition, there is evidence showing that mesenchaymal stromal cell-derived exosomes containing miRNAs can be used for monitoring and treatment of various diseases such as stroke. Here, we summarized various aspects of miRNA applications in different stages of stroke.",
keywords = "biomarker, exosome, meseanchaymal stromal cell, microRNA, stroke",
author = "Hamed Mirzaei and Fatemeh Momeni and Leila Saadatpour and Amirhossein Sahebkar and Mohammad Goodarzi and Aria Masoudifar and Shirin Kouhpayeh and Hossein Salehi and Mirzaei, {Hamid Reza} and Jaafari, {Mahmoud Reza}",
year = "2018",
month = "2",
day = "1",
doi = "10.1002/jcp.25787",
language = "English (US)",
volume = "233",
pages = "856--865",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - MicroRNA

T2 - Relevance to stroke diagnosis, prognosis, and therapy

AU - Mirzaei, Hamed

AU - Momeni, Fatemeh

AU - Saadatpour, Leila

AU - Sahebkar, Amirhossein

AU - Goodarzi, Mohammad

AU - Masoudifar, Aria

AU - Kouhpayeh, Shirin

AU - Salehi, Hossein

AU - Mirzaei, Hamid Reza

AU - Jaafari, Mahmoud Reza

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Stroke is a life-threatening disease that accounts for a considerable burden of mortality in both developing and developed world. Identification of specific biomarkers for stroke and its outcomes can greatly contribute to improved care of patients. MicroRNAs (miRNAs) are known as novel biomarkers that could be used as diagnostic, prognostic, and therapeutic biomarkers. Various studies have shown that miRNAs have key roles in the pathogenesis of stroke, and its complications and outcomes. In addition, there is evidence showing that mesenchaymal stromal cell-derived exosomes containing miRNAs can be used for monitoring and treatment of various diseases such as stroke. Here, we summarized various aspects of miRNA applications in different stages of stroke.

AB - Stroke is a life-threatening disease that accounts for a considerable burden of mortality in both developing and developed world. Identification of specific biomarkers for stroke and its outcomes can greatly contribute to improved care of patients. MicroRNAs (miRNAs) are known as novel biomarkers that could be used as diagnostic, prognostic, and therapeutic biomarkers. Various studies have shown that miRNAs have key roles in the pathogenesis of stroke, and its complications and outcomes. In addition, there is evidence showing that mesenchaymal stromal cell-derived exosomes containing miRNAs can be used for monitoring and treatment of various diseases such as stroke. Here, we summarized various aspects of miRNA applications in different stages of stroke.

KW - biomarker

KW - exosome

KW - meseanchaymal stromal cell

KW - microRNA

KW - stroke

UR - http://www.scopus.com/inward/record.url?scp=85015370532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015370532&partnerID=8YFLogxK

U2 - 10.1002/jcp.25787

DO - 10.1002/jcp.25787

M3 - Review article

C2 - 28067403

AN - SCOPUS:85015370532

VL - 233

SP - 856

EP - 865

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 2

ER -